BioInvent Has Entered Into a Clinical Trial Collaboration and Supply Agreement to Evaluate BI-1206 in Combination With KEYTRUDA® in Advanced Solid Tumors

December 18, 2019   |   December 2019 Bond Updates
LUND, Sweden, Dec. 18, 2019 /PRNewswire/ -- BioInvent International AB ("BioInvent" or the "Company") (OMXS: BINV) today announces that it has entered into a clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ., USA, to evaluate the...

View more at: https://www.prnewswire.com:443/news-releases/bioinvent-has-entered-into-a-clinical-trial-collaboration-and-supply-agreement-to-evaluate-bi-1206-in-combination-with-keytruda-in-advanced-solid-tumors-300976692.html
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/